Take our comprehensive survey »

If you have hyperacusis, start here. This is your chance to have a real influence in helping researchers understand life with hyperacusis.

Learn about the Hyperacusis Device »

A novel hyperacusis hybrid device, developed by Dr. Craig Formby of the University of Alabama and Dr. David Eddins of the University of South Florida, will be used in an upcoming clinical trial.

Explore our research »

We are a non-profit charity dedicated to the development of effective treatments for hyperacusis and to funding research which will eliminate the underlying mechanisms that cause hyperacusis.

Patient Stories »

Sufferers are from all walks of life. Hyperacusis often has a significant impact on every part of a person’s life, from their work, their home environment, and virtually every social setting.

Polley Research Lab visit at Massachusetts Eye and Ear

Bryan Pollard, President of Hyperacusis Research, recently visited the Polley research lab at Mass. Eye and Ear Infirmary, a Harvard Medical School teaching hospital. The research overview was led by Pooja Balaram, PhD, a postdoctoral fellow. The research lab focuses on the mechanisms

Hyperacusis highlighted at Mass Eye and Ear Gala

Bryan Pollard, President of Hyperacusis Research, along with board member Michael Maholchic and his wife Betsy, attended the 8th annual Sense-ation! Gala for Massachusetts Eye and Ear Infirmary (MEEI). Over 500 people attended the event.

Lessons from Partnering for Cures

Partnering for Cures is an inspirational annual event focused on accelerating patient-centered solutions and creating meaningful collaborations. The event is sponsored by FasterCures, a Washington, D.C.-based Center of the Milken Institute, which has a goal

2017 Benefit Dinner a Huge Success

The 3rd annual Boston area Benefit Dinner was a tremendous success! We raised more than $17,000 to find a cure for hyperacusis. With your help, we are moving closer to uncovering the mechanisms of hyperacusis and working to eliminate noise-induced pain.